Brooks Laboratories Ltd is a pharmaceutical manufacturer focused on developing and producing a broad range of generic medicines. Its key segments include injectables, tablets, and dry syrups, with product lines covering antibiotics such as beta-lactams and cephalosporins as well as general critical care injectables. The company operates manufacturing facilities compliant with international quality standards located in India, serving both domestic and international markets. Revenue is generated through contract manufacturing and sales of pharmaceutical formulations distributed broadly across regulated and semi-regulated international markets. The company has obtained regulatory certifications from multiple countries to comply with international standards for pharmaceutical manufacturing.
Company address
Near Andheri Kurla Road, 201, The Summit Business Park, Mumbai, MH, 400
Kuvera gives you rich data insights and peer comparison for informed stock investment decisions. Just import your stock portfolio from your broking platform to Kuvera to track your investments and place your buy / sell orders.
1. Login to the Kuvera app or website and go to Invest section.
2. Select stocks and search for Brooks Laboratories Ltd or scroll over to Brooks Laboratories Ltd
3. Once you have understood its performance and financials, tap on Buy. You will be taken to your existing brokerage account for completing the transaction.
What is the Share Price of Brooks Laboratories Ltd?
The share price of Brooks Laboratories Ltd stocks is ₹135.50 as on 29/09/2025
What is the Market Cap of Brooks Laboratories Ltd?
Market capitalization or market cap in short, is the total value of all the stocks of a particular company. Market capitalization of Brooks Laboratories Ltd stock is ₹399.1 Cr on 29/09/2025.
In which sector / industry does Brooks Laboratories Ltd operate?
Brooks Laboratories Ltd operates in Healthcare / Drug Manufacturers - Specialty & Generic.
What was the revenue of Brooks Laboratories Ltd?
The revenue of Brooks Laboratories Ltd as of 2024 was ₹82.2 Cr
What is the PE ratio of Brooks Laboratories Ltd?
The price-to-earnings ratio (P/E ratio) in case of stocks of a company is the ratio between its
current share price relative to its earnings per share (EPS). A high P/E ratio indicates that the stock is
overvalued in relation to the earnings (revenue) generated. P/E ratio of Brooks Laboratories Ltd is
288.30 as on 29/09/2025.
What is the 52 week high price of Brooks Laboratories Ltd?
The 52 week high of Brooks Laboratories Ltd stock is ₹198.86.
What is the 52 week low price of Brooks Laboratories Ltd?
The 52 week low of Brooks Laboratories Ltd stock is ₹95.55.
Can fractional shares of Brooks Laboratories Ltd be purchased?
No, you cannot buy fractional shares of Brooks Laboratories Ltd, or any listed Indian company as of now.